A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX

被引:29
作者
Henry, Ryan E. [1 ]
Andrysik, Zdenek [1 ]
Paris, Ramiro [1 ]
Galbraith, Matthew D. [1 ]
Espinosa, Joaquin M. [1 ]
机构
[1] Univ Colorado, Dept Mol Cellular & Dev Biol, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词
apoptosis; BAX; cell fate choice; DR4; p53; TUMOR-SUPPRESSOR P53; COLORECTAL-CANCER CELLS; IN-VIVO; DNA-DAMAGE; TARGET GENES; TRANSCRIPTIONAL REGULATION; PUMA; EXPRESSION; DEATH; ACTIVATION;
D O I
10.1038/emboj.2011.498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cellular response to p53 activation varies greatly in a stimulus- and cell type-specific manner. Dissecting the molecular mechanisms defining these cell fate choices will assist the development of effective p53-based cancer therapies and also illuminate fundamental processes by which gene networks control cellular behaviour. Using an experimental system wherein stimulus-specific p53 responses are elicited by non-genotoxic versus genotoxic agents, we discovered a novel mechanism that determines whether cells undergo proliferation arrest or cell death. Strikingly, we observe that key mediators of cell-cycle arrest (p21, 14-3-3r) and apoptosis (PUMA, BAX) are equally activated regardless of outcome. In fact, arresting cells display strong translocation of PUMA and BAX to the mitochondria, yet fail to release cytochrome C or activate caspases. Surprisingly, the key differential events in apoptotic cells are p53-dependent activation of the DR4 death receptor pathway, caspase 8-mediated cleavage of BID, and BID-dependent activation of poised BAX at the mitochondria. These results reveal a previously unappreciated role for DR4 and the extrinsic apoptotic pathway in cell fate choice following p53 activation. The EMBO Journal (2012) 31, 1266-1278. doi:10.1038/emboj.2011.498; Published online 13 January 2012
引用
收藏
页码:1266 / 1278
页数:13
相关论文
共 56 条
[1]   A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint [J].
Beckerman, Rachel ;
Donner, Aaron J. ;
Mattia, Melissa ;
Peart, Melissa J. ;
Manley, James L. ;
Espinosa, Joaquin M. ;
Prives, Carol .
GENES & DEVELOPMENT, 2009, 23 (11) :1364-1377
[2]   Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[3]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[4]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[5]   Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo [J].
Burns, TF ;
Bernhard, EJ ;
El-Deiry, WS .
ONCOGENE, 2001, 20 (34) :4601-4612
[6]  
Chan TA, 2000, GENE DEV, V14, P1584
[7]   PUMA couples the nuclear and cytoplasmic proapoptotic function of p53 [J].
Chipuk, JE ;
Bouchier-Hayes, L ;
Kuwana, T ;
Newmeyer, DD ;
Green, DR .
SCIENCE, 2005, 309 (5741) :1732-1735
[8]   PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis [J].
Chipuk, Jerry E. ;
Green, Douglas R. .
CELL CYCLE, 2009, 8 (17) :2692-2696
[9]   Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation [J].
Das, Sanjeev ;
Raj, Lakshmi ;
Zhao, Bo ;
Kimura, Yuki ;
Bernstein, Alan ;
Aaronson, Stuart A. ;
Lee, Sam W. .
CELL, 2007, 130 (04) :624-637
[10]   Stimulus-specific transcriptional regulation within the p53 network [J].
Donner, Aaron Joseph ;
Hoover, Jennifer Michelle ;
Szostek, Stephanie Aspen ;
Espinosa, Joaquin Maximiliano .
CELL CYCLE, 2007, 6 (21) :2594-2598